NAFDAC Approves New Malaria Vaccine Trial In Nigeria.The clinical trial is to start nationwide, according to the National Agency for Food and Drug Administration and Control (NAFDAC).
As a result, it has mandated that each pharmaceutical company establish a Pharmacovigilance (PV) surveillance section.
YOU MAY ALSO LIKE: Tinubu Approves A 114% Pay Raise For All Politicians
PV will revolutionize things, according to the Director-General, Prof. Mojisola Adeyeye, who spoke over the weekend in Lagos.
Sayo Akintola, a resident media consultant, released a statement yesterday on behalf of the DG emphasizing the need for the sector to put in place procedures to ensure product monitoring along the supply chain.
She insisted that defined objectives, goals, and tactics must be conceptualized in order to complete the mission.
Marketing Authorization Holders (MAHs), according to Adeyeye, must, as a matter Train and involve relevant stakeholders on the critical requirement for pharmacovigilance and the usage of appropriate reporting platforms for Adverse Drug Reactions/Adverse Events Following Immunization (ADR/AEFI) to NAFDAC.
In order to advance the industry, she argued that players in Nigeria must ensure the long-term safety of medicinal products. She urged adherence to the PV initiative and other relevant regulations.
The six pharmacovigilance centers set up across the geographical zones, according to Adeyeye, would be enhanced to perform admirably.
The executive director of NAFDAC told Nigerians that she would personally oversee the exercise.
According to her, community pharmacists are essential in this endeavor because they reach the population based on facts that are readily available, she stated.
Since community pharmacists are also active in immunization, according to Adeyeye, it is crucial It is imperative that access to their PV systems be made in order to confirm adherence to rules and regulations.
YOU MAY ALSO LIKE: UK Stops Tariffs On Goods From Nigeria And 64 Other Countries
Recalling, Adeyeye claimed that since its foundation, NAFDAC has adopted a variety of initiatives to guarantee the safe use of medical items in the nation.
She claimed that recently, the COVID-19 epidemic brought PV to the forefront and emphasized it to achieve the African Union Smart Safety Surveillance (AU 3S) on the continent.
A great development indeed.